loading
Schlusskurs vom Vortag:
$3.56
Offen:
$3.61
24-Stunden-Volumen:
640.28K
Relative Volume:
0.57
Marktkapitalisierung:
$254.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-2.6364
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+19.01%
1M Leistung:
+39.56%
6M Leistung:
-49.93%
1J Leistung:
-34.31%
1-Tages-Spanne:
Value
$3.43
$3.62
1-Wochen-Bereich:
Value
$2.855
$3.62
52-Wochen-Spanne:
Value
$1.865
$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name
Firmenname
Terns Pharmaceuticals Inc
Name
Telefon
650-525-5535 EXT.101
Name
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Name
Mitarbeiter
59
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
TERN's Discussions on Twitter

Vergleichen Sie TERN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TERN
Terns Pharmaceuticals Inc
3.48 254.91M 0 -95.90M -79.09M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.27 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.12 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
650.98 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
260.44 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.76 26.40B 3.81B -644.79M -669.77M -6.24

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-28 Eingeleitet William Blair Mkt Perform
2024-10-31 Eingeleitet Oppenheimer Outperform
2023-06-22 Eingeleitet Mizuho Buy
2023-06-07 Eingeleitet Jefferies Buy
2023-05-31 Eingeleitet ROTH MKM Buy
2023-05-08 Eingeleitet BMO Capital Markets Outperform
2023-02-14 Eingeleitet JMP Securities Mkt Outperform
2023-02-07 Eingeleitet UBS Buy
2022-09-12 Eingeleitet H.C. Wainwright Neutral
2021-09-14 Fortgesetzt Goldman Buy
2021-03-02 Eingeleitet Cowen Outperform
2021-03-02 Eingeleitet Goldman Buy
2021-03-02 Eingeleitet JP Morgan Overweight
Alle ansehen

Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten

pulisher
09:50 AM

What is Terns Pharmaceuticals Inc (TERN) Stock Return on Shareholders’ Capital? - Sete News

09:50 AM
pulisher
May 01, 2025

Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel

Apr 30, 2025
pulisher
Apr 29, 2025

Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX

Apr 29, 2025
pulisher
Apr 27, 2025

Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX

Apr 27, 2025
pulisher
Apr 25, 2025

A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

TERN overperforms with a 2.86 increase in share price - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

TERN’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Outperform Rating from JMP Securities - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates - ADVFN

Apr 21, 2025
pulisher
Apr 18, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock Position Raised by LPL Financial LLC - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Alliancebernstein L.P. Has $2.01 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Vanguard Group Inc. Has $21.44 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Mizuho maintains Outperform on Terns Pharma, $14 target By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 14, 2025

Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback - Bloomberg.com

Apr 14, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 28,330 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

TERN Shares Experience Decline in Value - knoxdaily.com

Apr 11, 2025
pulisher
Apr 10, 2025

Norges Bank Acquires New Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 10, 2025
pulisher
Apr 07, 2025

Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround - Yahoo Finance

Apr 07, 2025
pulisher
Apr 07, 2025

Such Is The Power Of Terns Pharmaceuticals Inc (NASDAQ: TERN) - stocksregister.com

Apr 07, 2025
pulisher
Apr 03, 2025

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance

Apr 03, 2025
pulisher
Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India

Apr 02, 2025
pulisher
Apr 01, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN

Apr 01, 2025
pulisher
Mar 31, 2025

Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st

Mar 31, 2025
pulisher
Mar 31, 2025

HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com

Mar 26, 2025
pulisher
Mar 25, 2025

Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World

Mar 23, 2025

Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Terns Pharmaceuticals Inc-Aktie (TERN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Jung Melita Sun
Chief Business Officer
Nov 30 '24
Buy
5.11
2,250
11,498
2,250
Burroughs Amy L.
Chief Executive Officer
Nov 30 '24
Buy
5.11
510
2,606
19,609
Kuriakose Emil
Chief Medical Officer
Jan 02 '25
Sale
5.71
4,481
25,607
54,269
Vignola Mark J.
Chief Financial Officer
Jan 06 '25
Sale
5.80
9,059
52,500
74,752
Vignola Mark J.
Chief Financial Officer
Jan 02 '25
Sale
5.72
8,129
46,524
83,811
Quigley Jill M.
Director
Jan 06 '25
Sale
5.79
8,760
50,758
0
Quigley Jill M.
Director
Jan 02 '25
Sale
5.72
6,240
35,702
8,760
$72.51
price down icon 0.01%
$21.58
price up icon 2.96%
$32.56
price up icon 0.06%
$29.24
price up icon 18.78%
$105.61
price up icon 3.06%
biotechnology ONC
$256.40
price up icon 0.63%
Kapitalisierung:     |  Volumen (24h):